CID 6440491

Neoxaline

Structural Information

Molecular Formula
C23H25N5O4
SMILES
CC(C)(C=C)C12CC(C(=O)N\3C1(NC(=O)/C3=C\C4=CN=CN4)N(C5=CC=CC=C25)OC)O
InChI
InChI=1S/C23H25N5O4/c1-5-21(2,3)22-11-18(29)20(31)27-17(10-14-12-24-13-25-14)19(30)26-23(22,27)28(32-4)16-9-7-6-8-15(16)22/h5-10,12-13,18,29H,1,11H2,2-4H3,(H,24,25)(H,26,30)/b17-10+
InChIKey
HHLNXXASUKFCCX-LICLKQGHSA-N
Compound name
(14E)-11-hydroxy-14-(1H-imidazol-5-ylmethylidene)-2-methoxy-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.01,13.03,8]hexadeca-3,5,7-triene-12,15-dione
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

6
References

34
Patents

435.19064 Da
Monoisotopic Mass

2.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 436.19792 200.9
[M+Na]+ 458.17986 208.6
[M+NH4]+ 453.22446 206.7
[M+K]+ 474.15380 207.2
[M-H]- 434.18336 198.7
[M+Na-2H]- 456.16531 202.2
[M]+ 435.19009 201.1
[M]- 435.19119 201.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe